Broncus Holding (HKSE:02216) Other Financing: HK$0.22 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02216 Broncus Holding Corp HKSE:02216
43 GF Score
Price HK$0.66
GF Value HK$0.15
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Broncus Holding Other Financing?

Broncus Holding HKSE:02216 +1.55% 43 Other Financing is HK$0.22 Mil as of Jun. 2026. GuruFocus rates HKSE:02216 with a GF Score™ of 43/100 and a GF Value™ of HK$0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Broncus Holding's Other Financing for the six months ended in Jun. 2026 was HK$0.20 Mil.

Broncus Holding's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0.22 Mil.

Broncus Holding Other Financing Historical Data

* Premium members only.

The historical data trend for Broncus Holding's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Broncus Holding Other Financing Chart

Broncus Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial -65.48 -0.76 -0.65 -0.65 -0.03

Broncus Holding Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.40 -0.26 -0.06 0.02 0.20
HKSE:02216
43GF Score
Broncus Holding Corp HKSE:02216
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Broncus Holding Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of HK$0.22 Mil mean?
Broncus Holding (HKSE:02216) has a Other Financing of HK$0.22 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Broncus Holding and its competitors.
Is Broncus Holding's Other Financing too high?
Broncus Holding's current Other Financing is HK$0.22 Mil. Overall, Broncus Holding has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's Other Financing compare to ABT and SYK?
Broncus Holding's Other Financing of HK$0.22 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Broncus Holding and its competitors. Broncus Holding's current Other Financing is HK$0.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Based on GuruFocus' analysis, Broncus Holding (HKSE:02216) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.66 — trading 336.7% above its estimated fair value. The current Other Financing is HK$0.22 Mil. Broncus Holding's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Broncus Holding (HKSE:02216), the current Other Financing is HK$0.22 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Broncus Holding (HKSE:02216) Overvalued in 2026?

Based on GuruFocus' analysis, Broncus Holding stock appears to be overvalued. The current stock price of HK$0.66 is trading 336.7% above its estimated GF Value™ of HK$0.15. GuruFocus considers Broncus Holding to be Significantly Overvalued.

Key valuation signals for HKSE:02216:

  • Other Financing: HK$0.22 Mil
  • GF Value™: HK$0.15 vs. price of HK$0.66 (336.7% above fair value)
  • GF Score™: 43/100 with 7 warning signs

No single metric tells the full story. See the HKSE:02216 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Broncus Holding Business Description

Address No. 88 Jiangling Road, Xixing Street, Room 801, 8th Floor, Building 8, Binjiang District, Hangzhou, CHN
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
43GF Score

Get the complete analysis for HKSE:02216

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.66
Price
HK$0.15
GF Value